Impact BioMedical OverviewImpact BioMedical EBIT
EBIT (Earnings Before Interest and Taxes) analysis for IBO.
Quarterly EBIT
-$2.29M
↓ 127.31% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$11.33M
↑ 52.61% YoY
Trailing 12 months ending Mar 31, 2026
Impact BioMedical OverviewEBIT (Earnings Before Interest and Taxes) analysis for IBO.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026